144 related articles for article (PubMed ID: 6319859)
1. Physical separation of the agonist and antagonist forms of a mu opiate receptor?
Jauzac P; Puget A; Meunier JC
Life Sci; 1983; 33 Suppl 1():195-8. PubMed ID: 6319859
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of two molecular forms of a mu-opioid receptor type by sodium ions, manganese ions and by guanyl-5'-yl imidodiphosphate.
Jauzac P; Frances B; Puget A; Moisand C; Meunier JC
J Recept Res; 1986; 6(1):1-25. PubMed ID: 3012080
[TBL] [Abstract][Full Text] [Related]
3. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
Frances B; Puget A; Moisand C; Meunier JC
Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960
[TBL] [Abstract][Full Text] [Related]
4. Distinct molecular forms of opiate binding in the frog brain.
Puget A; Jauzac P; Meunier JC
Life Sci; 1983; 33 Suppl 1():199-202. PubMed ID: 6319860
[TBL] [Abstract][Full Text] [Related]
5. 5'-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution.
Mollereau C; Pascaud A; Baillat G; Mazarguil H; Puget A; Meunier JC
J Biol Chem; 1988 Dec; 263(34):18003-8. PubMed ID: 2848020
[TBL] [Abstract][Full Text] [Related]
6. Divalent cations: do they stabilize the agonist (12S) form of the mu opioid receptor?
Jauzac P; Frances B; Puget A; Meunier JC
Neuropeptides; 1984 Dec; 5(1-3):125-8. PubMed ID: 6099479
[TBL] [Abstract][Full Text] [Related]
7. Solubilization of two molecular forms of the frog brain opioid receptor.
Puget A; Frances B; Jauzac P; Meunier JC
Neuropeptides; 1984 Dec; 5(1-3):129-32. PubMed ID: 6099480
[TBL] [Abstract][Full Text] [Related]
8. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
9. [Opiate receptor(s) of the frog brain: soluble-phase separation of the macromolecular complexes of an agonist and an antagonist].
Puget A; Meunier JC
C R Seances Acad Sci III; 1983; 296(10):475-8. PubMed ID: 6307492
[TBL] [Abstract][Full Text] [Related]
10. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
Frances B; Moisand C; Meunier JC
Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
[TBL] [Abstract][Full Text] [Related]
11. Characterization of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment.
Attali B; Vogel Z
Brain Res; 1990 May; 517(1-2):182-8. PubMed ID: 2165432
[TBL] [Abstract][Full Text] [Related]
12. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
13. The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein.
Porthé G; Francés B; Verrier B; Cros J; Meunier JC
Life Sci; 1988; 43(6):559-67. PubMed ID: 2841553
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
Sadée W; Rosenbaum JS; Herz A
J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
[TBL] [Abstract][Full Text] [Related]
15. Guanine nucleotides inhibit binding of agonists and antagonists to soluble opiate receptors.
Koski G; Simonds WF; Klee WA
J Biol Chem; 1981 Feb; 256(4):1536-8. PubMed ID: 6257676
[TBL] [Abstract][Full Text] [Related]
16. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
Richards ML; Sadée W
Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
[TBL] [Abstract][Full Text] [Related]
17. [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate.
Kurowski M; Rosenbaum JS; Perry DC; Sadée W
Brain Res; 1982 Oct; 249(2):345-52. PubMed ID: 6291717
[No Abstract] [Full Text] [Related]
18. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
Tao PL; Law PY; Loh HH
J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
[TBL] [Abstract][Full Text] [Related]
19. Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
Tolkovsky AM
Mol Pharmacol; 1982 Nov; 22(3):648-56. PubMed ID: 6296657
[TBL] [Abstract][Full Text] [Related]
20. Opiate receptor thermodynamics: agonist and antagonist binding.
Hitzemann R; Murphy M; Curell J
Eur J Pharmacol; 1985 Jan; 108(2):171-7. PubMed ID: 2984022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
